Literature DB >> 31096216

Lung Ultrasound to Assess the Etiology of Persistent Pulmonary Hypertension of the Newborn (LUPPHYN Study): A Pilot Study.

Beatriz Del Rey Hurtado de Mendoza1, Joan Sánchez-de-Toledo2,3, Sara Bobillo Perez4, Mónica Girona1,5, Mónica Balaguer Gargallo5, Javier Rodríguez-Fanjul6,7.   

Abstract

INTRODUCTION: Persistent pulmonary hypertension of the newborn (PPHN) is a neonatal syndrome associated with significant morbidity and mortality that is caused by the failure of postnatal drop in pulmonary vascular resistance. In extreme cases, patients may require extracorporeal membrane oxygenation therapy (ECMO). The aim of this study was to explore lung ultrasound (LUS) patterns in newborns with PPHN requiring ECMO. PATIENTS AND METHODS: From January 2014 to January 2018, LUS was performed on patients with PPHN admitted for ECMO treatment. PPHN diagnosis was based on clinical and echocardiographic findings. LUS was performed before patients underwent ECMO cannulation. An underlying diagnosis was made taking into account the patient's complete medical history, excluding LUS information. A blinded physician, unaware of the patient's clinical condition, analyzed the stored ultrasound images. Results were then compared with chest x-ray (CXR) diagnoses.
RESULTS: Seventeen patients were recruited; 12 were male (70.6%). The median gestational age was 38.7 weeks, with 13 term newborns (76.5%). Twelve were cannulated for VA ECMO, with a median ECMO run of 111.2 h. Six patients (35%) survived. Patients with alveolar capillary dysplasia with misaligned pulmonary veins, fetal ductus arteriosus constriction, or sepsis had normal LUS patterns (A-lines with lung sliding). LUS showed a better sensitivity (88.9%) and specificity (85%) than CXR (55.6 and 77.5%, respectively) in identifying patients with nonparenchymal lung disease.
CONCLUSIONS: LUS can provide essential information to help diagnose the underlying cause of PPHN in an earlier and more effective way than CXR. LUS is suitable for routine utilization in the intensive care unit.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Extracorporeal membrane oxygenation therapy; Lung ultrasound; Persistent pulmonary hypertension

Mesh:

Year:  2019        PMID: 31096216     DOI: 10.1159/000499047

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  2 in total

1.  Procalcitonin and lung ultrasound algorithm to diagnose severe pneumonia in critical paediatric patients (PROLUSP study). A randomised clinical trial.

Authors:  Javier Rodríguez-Fanjul; Carmina Guitart; Sara Bobillo-Perez; Mònica Balaguer; Iolanda Jordan
Journal:  Respir Res       Date:  2020-10-08

2.  Ultrasound findings in neonates with alveolar capillary dysplasia with misalignment of the pulmonary veins: report of two cases.

Authors:  Yan-Bing Lin; Bei Xia; Juan Cao; Zi-Jian Tang
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.